货号:GS40673
Sovipostobart is a humanized IgG1 kappa monoclonal antibody targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). It features a cleavable pro-domain designed to control its activity, functioning as both an immunostimulant and an antineoplastic agent. By blocking CTLA-4, it inhibits this immune checkpoint to enhance T cell activation and anti-tumor responses. It is being developed for cancer immunotherapy, aiming to improve efficacy and safety through its engineered pro-domain mechanism.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯